These highlights do not include all the information needed to use VIBERZI safely and effectively. See full prescribing information for VIBERZI.
VIBERZI (eluxadoline) tablets, for oral use, C-X
Initial U.S. Approval: 2015
INDICATIONS AND USAGE
VIBERZI is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhea (IBS-D). (1)
DOSAGE AND ADMINISTRATION
-
The recommended dosage in adults is 100 mg twice daily taken with food. (2)
-
The recommended dosage is 75 mg twice daily taken with food in patients who:
